Literature DB >> 19540038

Yolk sac tumor in the fourth ventricle: a case report.

Cui Gaoyu1, Guo Deyu, Chen Zhi, Feng Hua.   

Abstract

The nongerminomatous germ cell tumor occurring in the fourth ventricle is extremely rare. A 9-year-old boy presented with symptoms of obvious headache, projectile vomiting, diplopia and motor weakness. MRI scanning revealed lesions occupying the fourth ventricle, with dual-lateral ventricle expansion after gadolinium administration. Suboccipital craniectomy was performed and the tumor was removed by block resection. Twice intraoperative biopsy specimens revealed fiber vascular tissue and hemangioma. Histological examination revealed that the tumor consisted of loose network structures and Schiller-Duval bodies. Immunohistochemical study showed that the primitive germ cells were positive for placental alkaline phosphatase, alpha-fetoprotein, cytokeratin, vimentin, but negative for glial fibrillary acidic protein. The histological diagnosis was pure yolk sac tumor. Two years after surgery, he has suffered no tumor recurrence. A combination of surgical treatment, radiation and chemotherapy is mandatory.

Entities:  

Mesh:

Year:  2009        PMID: 19540038     DOI: 10.1016/j.clineuro.2009.05.009

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  3 in total

1.  Fourth ventricular mixed germ cell tumor demonstrating adipose tissue in a young adult.

Authors:  Akihiro Kuriu; Taro Shimono; Masatomo Kuwabara; Ryuichiro Ashikaga; Makoto Hosono; Takamichi Murakami
Journal:  Jpn J Radiol       Date:  2010-02-26       Impact factor: 2.374

2.  Unusual anatomic location of a primary intracranial yolk sac tumor.

Authors:  Anwar A Al-Masri; Nidal H Khasawneh; Tariq N Aladily
Journal:  Ann Saudi Med       Date:  2011 May-Jun       Impact factor: 1.526

3.  Intracranial pure yolk sac tumor in the anterior third ventricle of an adult: A case report.

Authors:  Suhong Zhao; Guangrui Shao; Weihua Guo; Xiubin Chen; Qingwei Liu
Journal:  Exp Ther Med       Date:  2014-09-02       Impact factor: 2.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.